We are live on
!
Find out more
Marshall Wace Portfolio holdings
AUM
$100B
1-Year Est. Return
35.1%
This Fund
S&P 500
This Quarter
Est. Return
+10%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$44.5B
AUM Growth
-$1.18B
(-2.6%)
Cap. Flow
-$4.15B
Cap. Flow
% of AUM
-9.34%
Top 10 Holdings %
Top 10 Hldgs %
9.83%
Holding
3,927
New
652
Increased
690
Reduced
847
Closed
1,056
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Biogen
BIIB
|
+$309M |
| 2 |
ExxonMobil
XOM
|
+$302M |
| 3 |
Amazon
AMZN
|
+$291M |
| 4 |
Citigroup
C
|
+$253M |
| 5 |
Shopify
SHOP
|
+$238M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Humana
HUM
|
+$383M |
| 2 |
Johnson & Johnson
JNJ
|
+$312M |
| 3 |
JPMorgan Chase
JPM
|
+$285M |
| 4 |
AT&T
T
|
+$191M |
| 5 |
Dollar General
DG
|
+$187M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 15.63% |
| 2 | Financials | 15.61% |
| 3 | Technology | 14.28% |
| 4 | Consumer Discretionary | 13.21% |
| 5 | Industrials | 5.22% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
151
Peabody Energy
BTU
$2.78B
| $65M | 0.15% |
2,462,138
+1,304,017
| +113% | +$35.8M |
|
152
CALL
Walmart Inc
WMT
$871B
| $64.9M | 0.15% |
1,372,500
+933,600
| +213% | +$44.3M |
|
|
BKI
153
DELISTED
Black Knight, Inc. Common Stock
BKI
| $64.7M | 0.15% |
1,047,263
-78,176
| -7% | -$4.75M |
|
154
Stryker
SYK
$127B
| $63.6M | 0.14% |
260,053
+249,187
| +2,293% | +$56.5M |
|
155
Dominion Energy
D
$62.5B
| $63.4M | 0.14% |
+1,033,402
| New | +$64.9M |
|
156
Hershey
HSY
$35.4B
| $63.3M | 0.14% |
273,397
+167,437
| +158% | +$38.6M |
|
157
Costco
COST
$415B
| $62.5M | 0.14% |
136,971
-227,374
| -62% | -$111M |
|
158
First Horizon
FHN
$12.1B
| $62.4M | 0.14% |
2,545,028
+74,476
| +3% | +$1.8M |
|
159
e.l.f. Beauty
ELF
$4.56B
| $62.2M | 0.14% |
1,124,445
+182,007
| +19% | +$8.91M |
|
160
BioMarin Pharmaceuticals
BMRN
$11.5B
| $62.1M | 0.14% |
600,272
+139,313
| +30% | +$13.1M |
|
161
Goldman Sachs
GS
$313B
| $61.9M | 0.14% |
180,381
+44,654
| +33% | +$15.5M |
|
162
PUT
iShares 20+ Year Treasury Bond ETF
TLT
$42.1B
| $61.5M | 0.14% |
+617,600
| New | +$62.2M |
|
163
Tradeweb Markets
TW
$21.3B
| $60.9M | 0.14% |
+937,318
| New | +$55.1M |
|
164
Intuitive Surgical
ISRG
$121B
| $60.7M | 0.14% |
228,744
+174,411
| +321% | +$42.5M |
|
165
EQT Corp
EQT
$33.2B
| $60.2M | 0.14% |
+1,779,373
| New | +$71.4M |
|
166
Flex
FLEX
$43.4B
| $60M | 0.14% |
3,712,195
-244,961
| -6% | -$3.68M |
|
167
Natera
NTRA
$37.5B
| $59.9M | 0.13% |
1,492,125
+262,940
| +21% | +$10.8M |
|
168
American Express
AXP
$223B
| $59.6M | 0.13% |
403,670
-109,539
| -21% | -$16.2M |
|
169
Workday
WDAY
$33.4B
| $59.6M | 0.13% |
356,060
+101,185
| +40% | +$15.8M |
|
170
SPDR Gold Trust
GLD
$131B
| $59.5M | 0.13% |
350,479
-147,800
| -30% | -$23.8M |
|
171
CALL
Berkshire Hathaway Class B
BRK.B
$1.07T
| $58.9M | 0.13% |
190,700
+41,500
| +28% | +$12.3M |
|
172
Take-Two Interactive
TTWO
$43B
| $58.7M | 0.13% |
563,851
+50,803
| +10% | +$5.5M |
|
173
Carnival Corporation Ltd
CCL
$36.1B
| $57.5M | 0.13% |
7,137,625
+4,973,876
| +230% | +$42.9M |
|
174
BioNTech
BNTX
$22.6B
| $57.5M | 0.13% |
382,397
+237,709
| +164% | +$36.6M |
|
175
CALL
Tesla
TSLA
$1.24T
| $56.9M | 0.13% |
462,200
+335,200
| +264% | +$63.5M |
|
Similar funds
Marshall Wace's Q4 2022 Portfolio in Review
As of Q4 2022, Marshall Wace held 3,927 positions worth $44.5B, down 2.6% from $45.6B the previous quarter. Its ten largest holdings account for 9.8% of the portfolio.
Marshall Wace withdrew a net $4.15B in Q4 2022, closing 1,056 positions and reducing 847 holdings. Its most notable exit was Humana, an estimated $383M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 16% of assets, up from 15% a quarter earlier, followed by Financials and Technology.
Against the trend, Marshall Wace opened a new position in Elevance Health worth $188M.
- Marshall Wace's largest Q4 2022 buy was Elevance Health: 366,649 shares worth $188M.
- Marshall Wace added most to Biogen in Q4 2022, an estimated $309M increase.
- Marshall Wace's biggest Q4 2022 reduction was Johnson & Johnson, cutting an estimated $312M.
- Marshall Wace fully exited Humana in Q4 2022, selling an estimated $383M.
- Marshall Wace's ten largest holdings make up 9.8% of its $44.5B portfolio in Q4 2022.
- Marshall Wace opened 652 new positions and closed 1,056 in Q4 2022.
- Marshall Wace's portfolio value fell 2.6% quarter-over-quarter to $44.5B.
Based on Marshall Wace's 13F filing for Q4 2022, filed 14 Feb 2023.